A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma

<div>Kaplan-Meier survival curves for the training set classified by neoplasm histologic grade, pathologic stage, and platelet qualitative. (a) Neoplasm histologic grade; (b) pathologic stage; (c) platelet qualitative. Patients of the training set are separated by neoplasm histologic grade, pathologic stage, or platelet qualitative into different subgroups, separately. OS time of different subgroups is compared and analyzed using Kaplan-Meier survival analysis.</div>

Disease Markers

fig4

Figure 4

Figure 4: A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma 